S

START | Barcelona

Research site

(Unclaimed)

Location

Avinguda de Vallcarca 151, Barcelona, Barcelona, Spain

Site insights

Top conditions

Top treatments

Tavapadon

Emricasan

Ribavirin

ARGX-113

Anecortave Acetate

Telaprevir

CVL-865

Peginterferon

Naloxone HCl

PPSGG

Parent organization

This site is a part of START

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 13 total trials

Comparison of Pomalidomide and Dexamethasone With or Without Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma Previously Treated With Lenalidomide and a Proteasome InhibitorDaratumumab/Pomalidomide/Dexamethasone vs Pomalidomide/Dexamethasone (EMN14)

The purpose of this study is to evaluate the effects of the addition of daratumumab to pomalidomide and dexamethasone in terms of progression-free su...

Active, not recruiting

Multiple Myeloma

Drug: Daratumumab

Drug: Pomalidomide

Fixed-Dose Trial in Early Parkinson's Disease (PD) (TEMPO-1)

The purpose of this study is to evaluate the clinical efficacy, safety and pharmacokinetics (PK) of 2 fixed doses of tavapadon and placebo in partici...

Active, not recruiting

Parkinson Disease

Drug: Tavapadon

Drug: Placebo

Flexible-Dose Trial in Early Parkinson's Disease (PD) (TEMPO-2)

The purpose of this study is to assess the efficacy, safety, tolerability and pharmacokinetics (PK) of flexible doses of tavapadon in participants wi...

Active, not recruiting

Parkinson Disease

Drug: Placebo

Drug: Tavapadon

Open-label Trial in Parkinson's Disease (PD) (TEMPO-4)

The purpose of this study is to evaluate the safety and efficacy of long-term administration of flexible doses of tavapadon in participants with Park...

Invitation-only

Parkinson Disease

Drug: Tavapadon